FDA approves Synapse Biomedical's diaphragm pacing system | Crain's Cleveland Business
Oberlin-based Synapse Biomedical recently secured U.S. Food and Drug Administration premarket approval for its diaphragm pacing system for use in patients with spinal cord injuries (SCI) who rely on mechanical ventilation.
Source: crainscleveland.com